The presentations are titled “Application of PRINT Microparticle and Nanoparticle Technology Toward Preparation of Ophthalmic Suspension Formulations With Improved Tolerability and Efficacy” and “Precisely Engineered Biodegradable Intraocular Implants for the Sustained Release of Dexamethasone.”
More Articles on Ophthalmology:
American Academy of Ophthalmology Grants US Rep. Marsha Blackburn Visionary Award
How Ophthalmologists are Affected by Healthcare Cost Changes: 15 Statistics
Liquidia Technologies to Develop Ophthalmology-Focused Company
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.